Objectives: In eubacteria, RecA is essential for recombinational DNA repair and for stalled replication forks to resume DNA synthesis. Recent work has implicated a role for RecA in the development of antibiotic resistance in pathogenic bacteria. Consequently, our goal is to identify and characterize small-molecule inhibitors that target RecA both in vitro and in vivo.
Introduction
Tuberculosis (TB), a chronic bacterial infection caused by Mycobacterium tuberculosis, is responsible for significant morbidity and mortality worldwide. 1, 2 Moreover, the global emergence of multidrug-resistant strains that are resistant to both isoniazid and rifampicin, extensively drug-resistant strains and totally drug-resistant strains of M. tuberculosis has further complicated the prospects of TB control and elimination. 1, 2 Thus, these challenges underscore the urgent need for the development of new antituberculosis drugs with novel mechanisms of action that can be used in combination with the existing TB drugs to shorten the treatment of drug-susceptible strains as well. 1, 2 The bacterial SOS response system is a global response to DNA damage in which DNA repair and mutagenesis are induced. A central part of the SOS response involves the controlled derepression of a number of SOS genes, which are under the direct and indirect control of the LexA repressor. Another key protein involved in regulating the SOS response is RecA. 3 -6 Escherichia coli RecA (EcRecA) is the founding member of a nearly ubiquitous family of multifunctional proteins and is substantially conserved among eubacterial species. 3 In many bacteria, recA is expressed from a single promoter and is controlled by LexA. 4 However, in M. tuberculosis, recA is expressed from two promoters, one of which is DNA damage inducible, independently of LexA and RecA, while the other is regulated by LexA. The RecA protein plays a central role in various steps of homologous recombination, in the repair of broken DNA molecules and in the restart of stalled replication forks. 3, 6, 7 Many additional studies have provided compelling evidence that RecA is crucial for processes such as antigenic variation, 8 induction of toxin biosynthesis, 9 swarming motility 10 and synthesis of virulence factors 11 as well as in the evolution of antibiotic resistance. 12 -16 Others have noted that interfering with LexA activity results in the suppression of recA expression, which renders pathogenic E. coli unable to mutate and acquire susceptibility to ciprofloxacin or rifampicin. 11, 17 Notably, deletion of recA in a variety of bacteria including Staphylococcus aureus and E. coli conferred a reduction in the levofloxacin MIC by 2-to 8-fold, 18 suggesting that RecA can serve as a potential target for the development of antibacterial compounds. This notion has been corroborated in mycobacteria by genetic and genome-wide bioinformatics analysis. 19, 20 A forward chemical screen assay identified several small molecule inhibitors of EcRecA. 21 In this screen, suramin (also called germanin), a polysulphonated naphthylurea ( Figure S1B ; Figure S1 is available as Supplementary data at JAC Online), and suramin-like agents were found to inhibit EcRecA-catalysed ATPase and DNA strand exchange activity. 21 However, the mechanism underlying such inhibitory action of suramin and its role in the regulation of the SOS response has not been elucidated. In an attempt to delineate the range of suramin action, we reasoned that it might be useful to test its effect on mycobacterial RecA proteins because of its clinical use since the 1920s as an antitrypanosomal (sleeping sickness) and antifiliarial drug. 22 Furthermore, it has been widely used for the treatment of several advanced malignancies, including prostatic and adrenocortical cancer and some lymphomas and sarcomas. 23, 24 It is also active against viral hepatitis and other potential biological targets, including proteins/enzymes of signalling pathways such as growth factor receptors, P2 purinergic receptors and uncoupling G proteins from G protein-coupled receptors. 25, 26 In light of these pharmacological studies, we investigated its effect on mycobacterial RecA proteins in vitro and in vivo and explored the mechanism by which suramin exerts its inhibitory activity on the RecA protein.
In this study, we show that suramin is a potent inhibitor of all known biochemical activities of M. tuberculosis RecA protein (MtRecA) and that the mechanism underlying such inhibitory actions involves the ability of suramin to disassemble RecAsingle-stranded (ss) DNA filaments, regardless of whether the nucleoprotein filaments were formed in the presence of ATP or ATPgS. Importantly, additional evidence indicated that suramin blocked ciprofloxacin-inducible recA gene expression and the SOS response and augmented susceptibility to ciprofloxacin. These results open up new opportunities to consider chemical ways to disrupt the pathways controlled by RecA and sensitize multidrug-resistant and extensively drug-resistant strains of M. tuberculosis for better infection control and the development of new therapies.
Materials and methods

Biochemicals, strains and proteins
Suramin, ciprofloxacin and thin layer chromatography (TLC) polyethylenimine (PEI) cellulose plates were procured from Sigma Chemical Company. All other biochemicals were obtained either from GE Biosciences or Sigma Chemical Company (St Louis, MO, USA). Radiolabelled ATP was purchased from Bhabha Atomic Research Center, Mumbai. Mycobacterium smegmatis recA + and isogenic DrecA mutant was a kind gift of Elaine Davis, National Institute for Medical Research, London. EcRecA, MtRecA, M. smegmatis RecA (MsRecA) and M. tuberculosis LexA (MtLexA) were purified to homogeneity as previously described. 27 -30 The protein preparations were free of detectable exo-or endonuclease activity (data not shown). Polyclonal antibody to MtRecA was raised in rabbits and characterized as previously described. 29 
DNA substrates
Duplex DNA was annealed from oligonucleotides (ODNs) (Sigma-Genosys, Singapore). The ODN sequences were as follows: 83-mer ODN1, 5
′ -GATCTGTACGGCTGGACAGTGTTGTGAGTGAGTTGAAGATGGGAGGTAGTGTG CTAGGTGGCTTAGGAGAGAGTCGTTAGTGT-3 ′ ; 83-mer ODN2, 5 ′ -ACACTAAC GACTCTCTCCTAAGCCACCTAGCACACTACCTCCCATCTTCAACTCACTCACAACAC TGTCCAGCCGTACAGATC-3 ′ ; and biotinylated ssDNA, 5 ′ -biotin GCCGTGATC ACCAATGCAGATTGACGAACCTTTGCCCACGT-3 ′ . To form labelled duplex DNA, 5
′ 32 P-labelled ODN1 was annealed with an equimolar ratio of unlabelled ODN2 at 958C for 5 min followed by gradual cooling to 248C. 29 The reaction mixture was electrophoresed on a 10% polyacrylamide gel in 44.5 mM Tris-borate buffer (pH 8.3) containing 1 mM EDTA at 150 V for 7 h. The band corresponding to the 32 P-labelled duplex DNA was excised from the gel and eluted into a buffer containing 10 mM Tris-HCl (pH 7.5) and 1 mM EDTA. Circular ssDNA from bacteriophage M13 was prepared as previously described. 28, 29 The concentration of DNA was expressed in moles of nucleotide residues per litre.
DNA strand exchange assay
The strand exchange assay was performed as previously described. 28, 29 Briefly, reaction mixture (10 mL) containing 20 mM Tris-HCl (pH 7.5 for EcRecA and MtRecA; pH 7 for MsRecA), 3 mM dATP, 8 mM MgCl 2 , 5 mM ssDNA (83-mer ODN1) and 2.5 mM RecA (from the organism indicated) was incubated in the presence of an ATP regeneration system (5 mM phosphocreatine and 10 U/mL creatine phosphokinase). After incubation at 378C for 5 min, the indicated concentration of suramin was added and incubated for 5 min. The strand transfer reaction was initiated by the addition of 1 mM 32 P-labelled duplex DNA and incubation continued for an additional 10 min. The reaction was stopped by the addition of 2.5 mL of 5× stop buffer (5% SDS and 100 mM EDTA) followed by the addition of 1.5 mL of 10× electrophoresis dye [50% glycerol, 0.42% (w/v) bromophenol blue and 0.42% (w/v) xylene cyanol]. The deproteinized samples were loaded onto a 10% polyacrylamide gel and electrophoresed in 44.5 mM Tris-borate buffer (pH 8.3) containing 1 mM EDTA at 150 V for 7 h. The reaction products were visualized using a Fuji FLA-9000 phosphorimager scanner. The band intensities were quantified in a UVI-Tech gel documentation station using UVI-BandMap software version 97.04 and plotted using GraphPad Prism (version 5.0).
RecA coprotease assay
The coprotease assay was performed as previously described. 29 Reaction mixtures contained 20 mM Tris-HCl (pH 7.5 for EcRecA and MtRecA; pH 7 for MsRecA), 8 mM MgCl 2 , 1 mM DTT, 3 mM dATP, 5 mM ssDNA (83-mer ODN1) and 2.5 mM RecA from the specified bacterial species. After incubation for 5 min at 308C, suramin was added at the indicated concentrations and incubation was continued for 5 min at 308C. Subsequently, 5 mM MtLexA was added and the reaction mixtures were further incubated for 30 min at 308C. The reaction was terminated by boiling in Laemmli sample buffer. Samples were subjected to 12.5% SDS-PAGE and stained with silver nitrate. The band intensities were quantified in a UVI-Tech gel Suramin inhibits RecA activities and the SOS response 1835 JAC documentation station using UVI-BandMap version 97.04 and plotted using GraphPad Prism (version 5.0).
ATPase assay
The ATPase assay was performed in a 10 mL reaction mixture containing 20 mM Tris-HCl (pH 7.5), 1 mM DTT, 8 mM MgCl 2 , 5 mM M13 circular ssDNA, 2.5 mM RecA from the specified bacterial species and increasing concentrations of suramin. The reaction was initiated by the addition of 2 mM [a-32 P]ATP, incubated for 30 min at 378C and stopped by the addition of 25 mM EDTA. Aliquots (1.8 mL) were transferred onto polyethylenimine cellulose F sheets and developed with a solution containing 0.5 M LiCl and 1 M formic acid. The TLC sheets were air dried and the bands were visualized using a Fuji FLA-9000 phosphorimager. The band intensities were quantified in a UVI-Tech gel documentation station using UVI-BandMap version 97.04 and plotted using GraphPad Prism (version 5.0).
Atomic force microscopy (AFM)
The reaction (10 mL) was performed at 378C for 5 min in a buffer containing 20 mM Tris-HCl (pH 7.5), 3 mM ATPgS, 8 mM MgCl 2 , 5 mM ssDNA (2000 nucleotide-long fragment) and 2.5 mM MtRecA. Reaction mixtures were then incubated with 10 mM suramin, where specified, for 5 min. Aliquots (5 mL) from the respective reaction mixtures were deposited on a freshly cleaved mica surface. After 90 s, the mica surface was rinsed with ultrapure water and air dried. Imaging was done in air using a silicon-tip-onnitride-lever AFM probe (Agilent Technologies; force constant 21-98 N/m) and Agilent AFM controller operated in the tapping mode at a resolution of 512×512 pixels. Raw data were selected with Picoimage software and the same was used to 'flatten' AFM images with second-order polynomial fitting. The scan frequency was typically 1.5 Hz per line and the modulation amplitude was a few nanometres.
Assay for suramin-induced disassembly of RecA nucleoprotein filaments
Reaction mixtures (20 mL) contained 20 mM Tris-HCl (pH 7.5), 1 mM ATPgS or 3 mM dATP, 8 mM MgCl 2 , 1 mM DTT and 10 mM biotinylated ssDNA and 3 mM RecA from the indicated bacterial species. After incubation for 5 min at 378C, suramin was added to a final concentration of 50 and 100 mM, followed by incubation for an additional 15 min at 378C. To separate RecA bound to ssDNA from that of free RecA, neutravidin agarose beads (Thermo Scientific) were added and mixed well with the reaction mixture for 15 min at 378C. The suspension was centrifuged at 15 000 rpm for 10 min at 248C. RecA bound to ssDNA was released by heating in SDS -PAGE loading buffer at 1008C for 5 min. Aliquots were analysed by 10% SDS -PAGE followed by staining with silver nitrate. The band intensities were quantified in a UVI-Tech gel documentation station using UVI-BandMap software version 97.04 and plotted using GraphPad Prism (version 5.0).
Circular dichroism (CD)
The CD spectra of RecA proteins were recorded as previously described. 31 Reaction mixtures (700 mL) contained 20 mM Tris-HCl (pH 7.5), 1 mM RecA from the indicated species of bacteria, 3 mM dATP, 8 mM MgCl 2 and increasing concentrations of suramin. All CD experiments were performed on a Jasco-815 spectropolarimeter (Japan Spectroscopic Co., Tokyo, Japan) in a 0.2 cm path-length cuvette at 258C. The CD spectra of buffer alone were subtracted from RecA spectra using Jasco Spectra Analysis software. The CD spectra were obtained in the spectral region of 260 -190 nm in continuous mode (scanning speed, 20 nm/min; data pitch, 0.1 nm; bandwidth, 0.2 nm; response time, 1 s). The data were expressed as molar ellipticity and plotted with molar ellipticity as a function of wavelength using the software Origin 6.1.
Western blotting
Polyclonal antibodies generated against MtRecA were characterized as previously described. 29 Similarly, polyclonal antibodies against M. tuberculosis IHF were raised in rabbits and their characterization will be described elsewhere. M. smegmatis recA + and M. smegmatis DrecA strains were grown in Middlebrook 7H9 broth until A 600 of 0.4 and then with the indicated concentrations of suramin and ciprofloxacin for 6 h at 378C. The culture was harvested and bacterial cells were collected by centrifugation at 6000 rpm for 10 min at 48C. Pellets were resuspended in lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA and 5% glycerol) and incubated at 48C for 1 h with 100 mg/mL lysozyme and 1× protease inhibitor cocktail (Sigma). Cells were then intermittently sonicated on ice (Vibra Cell Sonicator, Sonics and Materials Inc., Danbury, CT, USA) in a pulse mode (45% duty cycle) at a power setting of 8 for 15 min. Cell-free lysate was obtained by centrifugation at 15 000 rpm for 1 h at 48C. Aliquots of cell-free lysates (100 mg) were subjected to SDS -PAGE and the proteins were electroblotted onto nitrocellulose membrane using a wet blotter (Bio-Rad) at 100 V for 90 min. Equal loading of proteins was ascertained by Coomassie staining of an identical gel. Nitrocellulose membranes were incubated with anti-RecA or anti-mIHF antibody followed by incubation with antirabbit secondary antibody and visualized by enhanced chemiluminescence.
Antimicrobial susceptibility assay using disc diffusion M. smegmatis mc 2 155 strain was grown in Middlebrook 7H9 broth (Difco) supplemented with 0.05% Tween 80 and 0.2% (v/v) glycerol. Cultures were grown at 378C to mid-exponential phase (OD 600 ¼ 0.6). Cells were pelleted, washed and resuspended in an equal volume of fresh media. Then, 100 mL of washed culture was spread evenly over the surface of a sterile Middlebrook 7H11 plate. Sterile filter paper discs ( 6 mm in diameter) were soaked in solution containing the indicated concentration of ciprofloxacin or increasing concentrations of suramin and a fixed amount of ciprofloxacin. The discs were placed on a Petri plate and incubated at 378C for 48 h.
Results and discussion
Suramin inhibits DNA strand exchange promoted by RecA proteins
The most extensively studied reaction promoted by the members of the RecA family of recombinases is the three-strand exchange between ssDNA and linear double-stranded DNA. 3, 7 In previous studies, 21 the effect of a single dose of suramin (100 mM) was tested on the kinetics of strand exchange promoted by EcRecA. In this study, we have systematically investigated the effect of increasing amounts of suramin on DNA strand exchange promoted by EcRecA and mycobacterial RecA proteins. Complete strand exchange between the pair of DNA substrates as shown in Figure S1 (A), results in the displacement of 32 P-labelled noncomplementary ssDNA from the duplex DNA. As a positive control, we first tested the effect of suramin on EcRecA ( Figure S1C ). In the absence of suramin, the reaction was robust, leading to the displacement of 90% ssDNA ( Figure S1C, lane 2) . In the presence of suramin, however, strand exchange was inhibited in a concentration-dependent manner ( Figure S1C, lanes 3 -11) . In parallel experiments with MtRecA and MsRecA, we observed Nautiyal et al.
that suramin inhibited strand exchange catalysed by them in a concentration-dependent manner ( Figure S1D and E, lanes 3 -11) . For a quantitative comparison, we determined the actual percentage of labelled ssDNA displaced with a phosphorimager and plotted it as a function of suramin concentration (Figure 1) . The data revealed that suramin inhibited strand exchange activity of EcRecA with an IC 50 value of 1.5 mM, while those of MsRecA and MtRecA had IC 50 values of 1 and 2 mM, respectively. The addition of suramin to an ongoing reaction inhibited strand exchange; however, the inhibition was 2-fold less (data not shown). Taken together, these results suggest that suramin inhibits DNA strand exchange with similar potency, regardless of the type of RecA. In control experiments, we observed that suramin had no measurable effect on the components of the ATP regeneration system and, in accordance with a previous report, 32 failed to bind DNA (data not shown).
Suramin inhibits ATP hydrolysis catalysed by RecA proteins
An important feature of the RecA family of recombinases is their ability to bind and hydrolyse ATP, which is essential for DNA strand exchange. 3, 6, 7 To further investigate the inhibitory mechanism(s) of suramin, we measured its effect on the ssDNA-dependent ATPase activity of RecA in an assay using [a-32 P]ATP. A schematic of this assay is shown in Figure S2 (A) ( Figure S2 is available as Supplementary data at JAC Online). The reaction products were analysed using TLC. Subsequent scanning of the TLC plates with a phosphorimager allowed for the quantification of ATP and ADP. In control reactions, in accordance with previous reports, 27, 28 we observed that ATP hydrolysis catalysed by EcRecA was more efficient compared with mycobacterial RecA proteins ( Figure S2B -D, lane 2) . Under similar conditions, suramin inhibited the ATPase activity of EcRecA in a concentration-dependent manner ( Figure S2B, lanes 3 -9) . Likewise, suramin had an analogous effect on the ATPase activity of mycobacterial RecA proteins ( Figure S2C and D, lanes 3 -9) . Quantification of the extent of ATP hydrolysis was measured and compared by phosphorimager analysis. The data revealed that suramin was able to inhibit ATP hydrolysis catalysed by EcRecA and MtRecA with considerably lower IC 50 values of 1.75 mM compared with the IC 50 value for MsRecA (Figure 2) . Using a UV cross-linking assay, we determined the extent of binding of [a-
32 P]ATP to RecA proteins in the absence and presence of increasing concentrations of suramin. These results indicated that suramin inhibited ATP binding to RecA proteins in a manner that mirrored the suppression of ATPase activity (data not shown), supporting the idea that it functions as a competitive inhibitor of ATP for the ATP-binding pocket of RecA proteins. Based on these studies, we speculate that suramin may interact with key residues involved in the binding of ATP and DNA, culminating in the inhibition of both ATPase and strand exchange functions.
Suramin inhibits coprotease activity of RecA proteins
In eubacteria, DNA damage results in the enhanced expression of 50 promoters of the SOS regulon involved in various DNA repair processes, among other functions; this phenomenon is called the SOS response. 6 The first step during the SOS response involves the RecA -ssDNA filament, which serves as a coprotease to cleave the LexA repressor bound to duplex DNA. 6 To investigate the effect of suramin on the coprotease activity of RecA proteins, we first formed RecA-ssDNA filaments in the presence of dATP and then added the indicated concentrations of suramin together with a fixed amount (5 mM) of MtLexA. After 30 min incubation, the reaction products were resolved by SDS-PAGE and visualized with silver stain. As previously reported, 33 cleavage of the MtLexA repressor by RecA generated two small peptides designated as P1 and P2 ( Figure S3A -C, lane 4; Figure S3 is available as Supplementary data at JAC Online), which correspond to the C-and N-terminal fragments of LexA, respectively. In the presence of suramin, the coprotease activity of RecA proteins was inhibited more severely as higher amounts of it were added to the reaction mixture ( Figure S3A -C, lanes 5 -14) . Using phosphorimager analyses, we have estimated the extent of inhibition of MtLexA cleavage and plotted it as a function of suramin concentration. These Suramin inhibits RecA activities and the SOS response data revealed that suramin exerted most potent inhibition on MtRecA compared with that on MsRecA or EcRecA (Figure 3) . One possible explanation for the variable IC 50 values in regard to the coprotease activity may be related to homologous versus heterologous enzyme -substrate combinations. We next sought to determine the effect of suramin on the coprotease activity of RecA proteins when MtLexA was bound to duplex DNA (the detailed protocol is available as Supplementary data at JAC Online). To this end, we first established optimum reaction conditions to ensure complete binding of MtLexA to its cognate duplex DNA (referred to as the Cheo box) using an electrophoretic mobility shift assay ( Figure S4 , available as Supplementary data at JAC Online). Under these conditions, and in the presence of a slight excess of cognate duplex DNA, we tested the effect of increasing concentrations of suramin on the coprotease activity of RecA proteins. Like the cleavage of free MtLexA, all three RecA proteins were able to cleave DNA-bound MtLexA to produce P1 and P2 peptides. The data shown in Figure S5 (available as Supplementary data at JAC Online), revealed that suramin inhibition manifested relatively at higher IC 50 values in the range of 7 -13 mM. Although the E. coli LexA-DNA crystal structure has suggested that LexA -operator DNA interaction exerts minimal interference with RecA coprotease activity, 34 inhibition of proteolytic cleavage of the DNA bound form of LexA required higher concentrations of suramin.
Suramin promotes the disassembly of MtRecA -ssDNA filaments
To gain insights into the molecular mechanism by which suramin inhibits RecA functions, we directly visualized the MtRecA-ssDNA filaments using AFM. In these experiments, we incubated reaction mixtures containing MtRecA, ssDNA (2000 nucleotide residues) and ATPgS and then with suramin as described in the Materials and methods section. Aliquots of the reaction mixture were transferred onto a mica surface for AFM visualization. In the absence of suramin, we found that .95% of MtRecA-ssDNA filaments exhibited an extended filamentous structure, suggesting cooperative polymerization of RecA (Figure 4a, arrows) . We note that these results are consistent with the characteristic features reported for EcRecA -ssDNA filaments by AFM visualization. 35 We then examined the effect of suramin on the structure of MtRecAssDNA filaments. We found that suramin was able to cause a substantial disruption and robust shrinkage of the MtRecA -ssDNA filaments (Figure 4b -d, arrows) , indicating that suramin promotes the disassembly of nucleoprotein filaments. AFM imaging also revealed that .90% (n ¼ 40 total molecules) of MtRecA -ssDNA filaments were denuded and found to be partially or totally devoid of RecA (data not shown). Significantly, although RecA binds to ssDNA in a highly cooperative, largely irreversible manner in the presence of ATPgS, 3 suramin was able to dislodge RecA from ssDNA.
To validate the above results and to obtain quantitative data, we developed a pull-down assay to assess the effect of suramin on RecA -ssDNA filaments ( Figure S6A ; Figure S6 is available as Supplementary data at JAC Online). To this end, we incubated biotinylated ssDNA with stoichiometric amounts of EcRecA or MtRecA in the presence of ATPgS or dATP (plus ATP regeneration system) to form nucleoprotein filaments. Under these conditions, .95% of both EcRecA and MtRecA were bound to ssDNA (data not shown). Using neutravidin-coated agarose beads, we separated ssDNA-bound RecA from that of unbound RecA. Subsequently, RecA was released from ssDNA as described in the Materials and methods section. Aliquots from the supernatant and pellet fractions were analysed by SDS-PAGE and visualized by silver staining. In the absence of DNA, we found most of the input EcRecA and MtRecA in the supernatant fraction ( Figure S6B and C, lanes 3  and 11) . On the other hand, in reactions performed in the presence of ssDNA and ATPgS, but lacking suramin, most of the input RecA was found in the pellet fraction ( Figure S6B and C, lane 4). However, similar reactions done in the presence of dATP contained slightly higher amounts of RecA in the supernatant ( Figure S6B, lane 13) . In contrast, in the presence of suramin, an increased amount of RecA was found in the supernatant fraction regardless of the presence of dATP or ATPgS ( Figure S6B ). Using phosphorimager analyses, we have estimated the amount of EcRecA or MtRecA bound to ssDNA and plotted it as a function of suramin concentration. The data indicate that suramin was able to dissociate .80% of RecA bound to ssDNA under these conditions ( Figure 5 ). Altogether, these results point towards the effectiveness of suramin in the disassembly of RecA nucleoprotein filaments.
Suramin binds and induces conformational changes in RecA proteins
To investigate the inhibitory mechanism of suramin in more detail, we sought to test whether suramin binds to RecA by using a CD spectropolarimeter as described in the Materials and methods section. Figure S7 (available as Supplementary data at JAC Online) depicts the CD spectra of assay buffer and RecA alone and the corresponding spectra of RecA in the presence of increasing concentrations of suramin. E. coli and mycobacterial RecA proteins exhibited similar CD spectra, with ellipticity minima of comparable amplitudes in the 210 -230 nm range. We observed significant changes in the CD spectra upon addition of increasing Nautiyal et al.
concentrations of suramin, indicating changes in the secondary structure of RecA protein. The spectra in the presence of suramin were clearly different from those of RecA alone, showing that some conformational change had occurred as a result of its interaction with suramin. Titration experiments showed that there was no significant change in the CD spectrum of RecA at suramin concentrations from 75 to 100 mM. The estimated secondary structure suggested that suramin produced an 8% -10% decrease in a-helix and a concomitant increase in random coil. We conclude that suramin binds directly to RecA protein and affects the secondary structure of the peptide backbone of RecA.
Suramin blocks ciprofloxacin-induced recA expression E. coli and other bacteria maintain genomic stability under conditions of DNA damage by activating a globally induced response, the SOS network, and the response is regulated at the level of transcription. 6 Our findings that suramin inhibits all known biochemical activities of RecA in vitro prompted us to examine its effect in vivo and whether its effect is attenuated in a recA mutant. To this end, we used M. smegmatis as a surrogate, because MtRecA and MsRecA are functionally similar, including in their responses to suramin (this study). The amino acid sequence identity between MsRecA and MtRecA is 89% and between MtRecA and EcRecA is 60% over their entire length; this is also conserved in their three-dimensional structures. 28, 36, 37 On the other hand, EcRecA and human Rad51 share 30% identity, in the region between amino acid residues 154 -374 of Rad51 and 33 -240 of RecA. 38 Rad51 family members are homologues of bacterial RecA. Although, like RecA, Rad51 catalyses ATPdependent DNA strand exchange, it is devoid of protease activity and the SOS response. A compound (B02) from the NIH Small Molecule Repository specifically inhibited human Rad51 (IC 50 ¼ 27.4 mM) but not EcRecA (IC 50 .250 mM), whereas two other compounds (A03 and A10) inhibited both human Rad51 and RecA, but not the structurally unrelated Rad54 protein. 39 However, it is unknown whether suramin exerts inhibitory effects on Rad51 or its paralogues.
Also, previous studies have shown that M. smegmatis recA expression is inducible by DNA-damaging agents. 40 Therefore, Suramin inhibits RecA activities and the SOS response 1839 JAC we sought to investigate recA expression in response to increasing concentrations of suramin. Ciprofloxacin was used as a positive control as this drug is known to induce the SOS response as well cell death in M. smegmatis. 41 Cultures of M. smegmatis recA + strain and its isogenic DrecA mutant were treated with increasing concentrations of suramin or with 25 mM ciprofloxacin. Cell-free lysates from these cells were analysed for recA expression by western blotting using anti-MtRecA antibodies. While the induction of RecA expression in the recA + strain was apparent in cultures treated with ciprofloxacin ( Figure 6a, lane 6) , no measurable expression was observed in cultures treated with suramin, even at several fold excess the amounts required for the inhibition of RecA activities in vitro (Figure 6a, lanes 3 -5) . In accordance with the specificity of the assay, we found no RecA cross-reactivity in suramin-or ciprofloxacin-treated and untreated cell-free lysates of DrecA strain (Figure 6b ). To further examine the effect of suramin on ciprofloxacin-induced recA expression and the SOS response, the M. smegmatis recA + strain and its isogenic DrecA mutant were cultured as described above. These cultures were treated with the indicated concentrations of suramin, ciprofloxacin or both. Cell-free lysates were analysed as described above. As observed above, ciprofloxacin was able to induce recA expression in the recA + strain (Figure 6c , lane 2). Under these conditions, suramin completely abolished ciprofloxacin-induced recA expression (Figure 6c, lanes 3 -6) . Likewise, suramin was able to exert its inhibitory effect in the presence of increasing concentrations of ciprofloxacin (Figure 6e) . In DrecA mutant cells, we found no cross-reactivity under these conditions, thus confirming the specificity of the assay (Figure 6d and f) . To further establish the specificity of suramin on recA expression leading to the suppression of the SOS response, we examined the levels of M. smegmatis IHF (mIHF), an essential nucleoid-associated protein, 42 in ciprofloxacin-or ciprofloxacin/suramin-treated wild-type and DrecA strains. We observed that the expression of IHF was not attenuated in the presence of a fixed amount of suramin and increasing concentrations of ciprofloxacin in both the recA + and DrecA mutant strains (Figure 6g and h) . These results further confirm that the inhibitory effect of suramin is on RecA and not on an 
Suramin displays bactericidal activity
Next, we sought to determine the bactericidal activity of suramin against M. smegmatis using a disc-diffusion assay. Sterile Whatman paper discs (6 mm in diameter) were soaked in solutions containing the indicated concentration of ciprofloxacin (used as a positive control), suramin or a fixed concentration of ciprofloxacin with increasing amounts of suramin. Discs were placed on the surface of Petri plates that had already been seeded with M. smegmatis. The Petri plates were incubated at 378C for 48 h. As shown in Figure 7 , the mean radius of the zone of 
Conclusions
Genetic evidence has disclosed that mutations are one of the primary mechanisms of resistance to antibacterial agents. The SOS regulon is a bacterial stress response to DNA damage that generates mutants by activating error-prone DNA polymerases. 6 The two key regulatory proteins of this pathway are LexA and RecA. In this study, we used mycobacterial RecA proteins together with EcRecA to elucidate the mechanism underlying suramin inhibition and its effect on the SOS response. Our observations reveal that suramin exerts its inhibitory effects on RecA at three crucial steps of the overall pathway of recombinational DNA repair ( Figure 8 ). Suramin is a potent inhibitor of ATP binding, ATPase activity and DNA strand exchange (Figure 8a ). The mechanism underlying such inhibitory action involves its ability to disassemble the RecA -ssDNA filament, an essential intermediate in all biological reactions catalysed by RecA. Of note, suramin by itself does not induce recA gene expression, but inhibits the coprotease activity of RecA and prevents recA expression in response to ciprofloxacin, thereby abolishing induction of the SOS response (Figure 8a -c) . However, with suramin we found a lack of correlation between the IC 50 values and various in vitro biochemical activities of RecA and bactericidal activity. This could be due to the multifunctional nature of RecA and the effect of different experimental conditions. A corollary of this is the multifunctional hepatitis C virus NS3 protein, which is a protease, DNA/RNA helicase and ATPase. 43 All three activities are potential drug targets. The IC 50 values for NS3 activities with respect to a variety of drugs/ inhibitors differ significantly from each other and from that of their in vivo antiviral activity. 43 Whereas our studies have revealed the mechanism underlying the inhibitory action of suramin on RecA, relatively higher concentrations were required to observe the inhibitory effect in vivo with respect to suppression of recA expression, SOS response and bactericidal activity. However, it is important to note that due to its strong negative charge, suramin may not be able to cross the very complex lipid-rich cell wall of M. smegmatis. Alternatively, or in addition, its poor action may be due to inadequate uptake, inactivation by bacterial metabolism or expulsion by bacterial efflux pumps. Among several strategies available for identifying drug targets, the activity-based approach has emerged as a promising new technique for target discovery and development. 44, 45 This work further expands on the proof-of-concept studies for the development of antimicrobials against RecA as activity-based inhibitors.
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